Motixafortide, cemiplimab, gemcitabine and nab-paclitaxel in metastatic pancreatic cancer: a single-arm phase 2 study with single-cell correlatives
Alexander G. Raufi, Edridge D’Souza, Michael May, Sarah Sedycias et autres
us (code pays fourni par la source)